Cargando…

Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study

BACKGROUND: Antiviral therapy cannot completely block the progression of hepatitis B to hepatocellular carcinoma (HCC). Furthermore, there are few predictors of early HCC progression and limited strategies to prevent progression in patients with HBV-related cirrhosis who receive nucleos(t)ide analog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Dan-Hong, Wang, Wei-Ping, Zhang, Qiang, Pan, Hong-Ying, Huang, Yi-Cheng, Zhang, Jia-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108039/ https://www.ncbi.nlm.nih.gov/pubmed/34007137 http://dx.doi.org/10.3748/wjg.v27.i17.2025

Ejemplares similares

Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis
por: Liu, Dong, et al.
Publicado: (2022)

Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study
por: Appel-da-Silva, Marcelo Campos, et al.
Publicado: (2016)

Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis
por: Yao, Xin, et al.
Publicado: (2021)

Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt
por: Yao, Xin, et al.
Publicado: (2021)

Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
por: Li, Man-Yu, et al.
Publicado: (2023)

Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis
por: Chen, Li-Xing, et al.
Publicado: (2020)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Retrospective analysis of complications related to endoscopic retrograde cholangio-pancreatography in patients with cirrhosis vs patients without cirrhosis
por: Bernshteyn, Michelle, et al.
Publicado: (2021)

Nucleoside analogs treatment delay the onset of hepatocellular carcinoma in patients with HBV-related cirrhosis
por: Bi, Jingfeng, et al.
Publicado: (2017)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care
por: Bohra, Anuj, et al.
Publicado: (2020)

Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis
por: Xu, Shi-Hao, et al.
Publicado: (2020)

African Americans are less likely to receive curative treatment for hepatocellular carcinoma
por: Sobotka, Lindsay A, et al.
Publicado: (2018)

Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Women receive more inpatient resections and ablations for hepatocellular carcinoma than men
por: Sobotka, Lindsay, et al.
Publicado: (2017)

Multivariate predictive model for asymptomatic spontaneous bacterial peritonitis in patients with liver cirrhosis
por: Tu, Bo, et al.
Publicado: (2020)

Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study
por: Liu, Bao-Chi, et al.
Publicado: (2023)

Development and validation of a prognostic nomogram for decompensated liver cirrhosis
por: Zhang, Wang, et al.
Publicado: (2022)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Risk factors, incidence, and morbidity associated with antibiotic-associated diarrhea in intensive care unit patients receiving antibiotic monotherapy
por: Zhou, Hong, et al.
Publicado: (2020)

Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
por: Lei, Xue-Fen, et al.
Publicado: (2018)

Diabetes mellitus may affect the long-term survival of hepatitis B virus-related hepatocellular carcinoma patients after liver transplantation
por: Zhang, Qing, et al.
Publicado: (2016)

Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study
por: Afify, Shimaa, et al.
Publicado: (2021)

Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study
por: Zhou, Jiang-Min, et al.
Publicado: (2023)

Usefulness of autotaxin for the complications of liver cirrhosis
por: Shao, Xue, et al.
Publicado: (2020)

Identification of predictive factors for post-transarterial chemoembolization liver failure in hepatocellular carcinoma patients: A retrospective study
por: Yuan, Min, et al.
Publicado: (2022)

Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn’s disease patients
por: Zhu, Xia, et al.
Publicado: (2019)

Portal vein computed tomography imaging characteristics and their relationship with bleeding risk in patients with liver cirrhosis undergoing interventional therapy
por: Song, Xue-Jing, et al.
Publicado: (2023)

Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis
por: Li, Shao-Hua, et al.
Publicado: (2017)

Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis
por: Yang, Jun, et al.
Publicado: (2016)

Natural history and outcomes of patients with liver cirrhosis complicated by hepatic hydrothorax
por: Romero, Sarah, et al.
Publicado: (2022)

Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma
por: Wang, Qiang, et al.
Publicado: (2019)

Hepatic Cirrhosis
Publicado: (1890)

Coexistent alcohol-related cirrhosis and chronic pancreatitis have a comparable phenotype to either disease alone: A comparative retrospective analysis
por: Lu, Michael, et al.
Publicado: (2023)

Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
por: Tajiri, Kazuto, et al.
Publicado: (2022)

Bacterial infection triggers and complicates acute-on-chronic liver failure in patients with hepatitis B virus-decompensated cirrhosis: A retrospective cohort study
por: Cao, Zhu-Jun, et al.
Publicado: (2020)

Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis
por: Darrat, Yousef H, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_da3jj14nvbvraj7llqso3ghrou